{"schema_version":"secwatch.filing_event.v1","accession":"0001682852-24-000035","form_type":"8-K","ticker":"MRNA","cik":"0001682852","company_name":"Moderna, Inc.","filed_at":"2024-07-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.104303+00:00","generated_at":"2026-05-31T18:07:46.071837+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Moderna appoints David Rubenstein to board; co-founders Langer and Berenson retire","bullets":["David Rubenstein (Carlyle Co-Founder) joins Moderna board effective Aug 5, 2024, replacing Stephen Berenson on Audit Committee.","Robert Langer and Stephen Berenson will retire from board on Aug 5, 2024; both will provide advisory services through Nov 1, 2026.","Dr. Langer's and Mr. Berenson's resignations not due to any disagreement with Moderna's operations or policies.","Board size fixed at eight directors; search ongoing for replacement with scientific/innovation experience."],"urls":{"canonical":"https://secwatch.observer/filing/0001682852-24-000035","json":"https://secwatch.observer/filing/0001682852-24-000035.json","markdown":"https://secwatch.observer/filing/0001682852-24-000035.md","text":"https://secwatch.observer/filing/0001682852-24-000035.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1682852/000168285224000035/0001682852-24-000035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1682852/000168285224000035/mrna-20240719.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T18:07:46.071837+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1bb0212e8a","claim":"Stephen Berenson resigned as Director at Moderna, Inc..","evidence_excerpt":"On July 19, 2024, Robert Langer and Stephen Berenson each notified Moderna, Inc. (the “Company”) of his resignation from the Board of Directors of the Company (the “Board”), including all committees on which he serves, effective August 5, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1682852/000168285224000035/0001682852-24-000035-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}]},{"claim_id":"40f65ae4fb","claim":"Robert Langer resigned as Director at Moderna, Inc..","evidence_excerpt":"On July 19, 2024, Robert Langer and Stephen Berenson each notified Moderna, Inc. (the “Company”) of his resignation from the Board of Directors of the Company (the “Board”), including all committees on which he serves, effective August 5, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1682852/000168285224000035/0001682852-24-000035-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}]},{"claim_id":"9ff1868446","claim":"David M. Rubenstein was appointed as Director at Moderna, Inc..","evidence_excerpt":"On July 19, 2024, the Board, upon the recommendation of the Nominating and Corporate Governance Committee, appointed David M. Rubenstein to the Board, effective August 5, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1682852/000168285224000035/0001682852-24-000035-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}